
Trident Lifeline Ltd. (TLL): Trident Lifeline Share Price rises 9.09% to Rs 413.60 today
Updated: 25 Sept 2026 • 3:36 pm
Posted by:

Trident Lifeline Ltd. (TLL) share price rose 9.09% to Rs 413.60 today, adding Rs 34.45 from the previous close, with market capitalisation at Rs 480.79 crore.
Trident Lifeline Share Price moved higher in today's session, with the stock ending at Rs 413.60 after a gain of 9.09%. The company now has a market capitalisation of Rs 480.79 crore, which places the move in a clear stock-specific context for investors tracking Trident Lifeline Share Price Today. The session also took place after a previous close of Rs 379.15, so the increase of Rs 34.45 is easy to verify from the price data itself.
For readers following Trident Lifeline Stock News, the important point is simple: the supplied data confirms the price rise, but it does not establish a company-specific catalyst. That makes the move relevant as a factual market event rather than a story with an assigned reason. The stock opened at Rs 378, touched Rs 417.05 and saw a low of Rs 368.2 during the session, which shows the full range within which the share price moved today. Turnover stood at Rs 6.4 crore, offering a traded-value reference for the session.
From a search perspective, this Trident Lifeline Share Price update matters because it combines a sharp daily rise with valuation, earnings and sector context. In today's Indian stock market, such moves often draw attention from readers scanning Stocks in News, Top Gainers Today and Share Market Today, but the verified facts here remain limited to price, turnover and company fundamentals. Univest users can use this article to read the move as a market update, not as a forecast.
Trident Lifeline Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 413.6 |
| Previous Close | Rs 379.15 |
| Today's Move | Rs 34.45 (+9.09%) |
| Open | Rs 378 |
| High | Rs 417.05 |
| Low | Rs 368.2 |
| Turnover | Rs 6.4 crore |
| Market Capitalisation | Rs 480.79 crore |
| Market Cap Category | Micro Cap |
Trident Lifeline Ltd. (TLL) rose to Rs 413.6 from the previous close of Rs 379.15, a move of Rs 34.45 or 9.09%. The stock opened at Rs 378, reached a high of Rs 417.05, recorded a low of Rs 368.2.
Trident Lifeline Share Price Today finished at Rs 413.60, up Rs 34.45 or 9.09% from the previous close of Rs 379.15. The stock opened at Rs 378, traded between Rs 368.2 and Rs 417.05, and closed near the upper end of that range. The day's move confirms a strong price rise in absolute and percentage terms, while turnover of Rs 6.4 crore provides the traded-value backdrop for the session. The supplied data confirms the share price gain, but it does not establish a company-specific reason for the move.
For readers tracking Trident Lifeline Share Price Live, the main takeaway is that the session ended with a clear upward change from the prior close. Trident Lifeline News Today therefore centres on the verified price event itself, rather than any unconfirmed trigger. On Univest, the same data can be followed alongside market updates and company snapshots for ongoing reference.
Trident Lifeline Ltd. (TLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 480.79 crore |
| P/E Ratio | 23.81x |
| P/B Ratio | 4.6x |
| ROE | 18.78% |
| ROCE | 19.17% |
| EPS | Rs 15.92 |
| Book Value Per Share | Rs 82.4 |
| Dividend Yield | 0% |
Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 23.81x, P/B 4.6x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.
Trident Lifeline Ltd. has a market capitalisation of Rs 480.79 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.81x, P/B at 4.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 23.81x |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.58x |
| Benchmark P/E Range | 3.48x to 757.76x |
| Company P/B Ratio | 4.6x |
| Benchmark Median P/B | 2.95x |
| Company ROE | 18.78% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 19.17% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 480.79 crore |
| Benchmark Median Market Cap | Rs 804.62 crore |
Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Trident Lifeline Ltd. (TLL) has a P/E ratio of 23.81x, which is below the benchmark median of 32.73x, a difference of -27.25%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.7%, a difference of +60.51%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.61%, a difference of +40.85%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,47,475.97 | 36.76 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,54,763.56 | 87.25 | 14.45 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,423.19 | 86.07 | 20.91 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,16,658.07 | 26.08 | 4.37 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,484.47 | 33.65 | 3.23 | 11.83 | 16 |
Trident Lifeline Ltd. (TLL) has a P/E ratio of 23.81x compared with the displayed peer median of 36.76x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 480.79 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Trident Lifeline
- Trident Lifeline Share Price rose 9.09% today to Rs 413.60, after closing at Rs 379.15 in the previous session.
- The stock moved between Rs 368.2 and Rs 417.05 during the day, with turnover of Rs 6.4 crore.
- Market capitalisation is Rs 480.79 crore, which places the company below the sector median of Rs 804.62 crore.
- P/E is 23.81, P/B is 4.6, EPS is Rs 15.92 and book value is Rs 82.4 per share.
- ROE is 18.78% and ROCE is 19.17%, both above the sector median and sector average in the supplied benchmark set.
About Trident Lifeline
Trident Lifeline Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied classification, the company belongs to a business area where valuation, earnings and capital efficiency are often compared closely with sector peers. The current Trident Lifeline Share Price update is therefore relevant not only for the day's move, but also for how the company fits into its industry set.
The available data does not include a detailed revenue breakdown, product list or segment split, so the safest description is to stay with the verified company context: Trident Lifeline is a listed pharmaceutical and drugs business on NSE and BSE tracking screens, with measurable earnings, book value and return ratios. For readers following Trident Lifeline Stock News, this makes the company a market participant whose share price can be assessed through both session moves and broader financial analysis on Univest.
Track Trident Lifeline Share Price on Univest
Use Trident Lifeline Ltd. (TLL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
On Univest, readers can track Trident Lifeline Share Price Today along with live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. The platform also helps users review Trident Lifeline Stock Analysis, Trident Lifeline Fundamental Analysis and company-specific market updates in one place.
For anyone watching Trident Lifeline Latest News or Trident Lifeline Share Price Update, Univest provides a clean way to follow the stock's factual profile without turning a price rise into a prediction. That keeps the focus on verified numbers, company context and sector comparison.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Trident Lifeline Share Price rise today?
Ans. The supplied data confirms a 9.09% rise to Rs 413.60, but it does not establish a company-specific catalyst. The move is still relevant because it was a clear same-day gain from Rs 379.15.
What is Trident Lifeline Share Price today?
Ans. Trident Lifeline Share Price today is Rs 413.60. That is Rs 34.45 above the previous close of Rs 379.15, and it places the stock among the session's notable movers in the Healthcare space.
How much did Trident Lifeline stock gain in percentage terms?
Ans. The stock gained 9.09% in the session. This rise came alongside a high of Rs 417.05 and a low of Rs 368.2, showing the full range of the day's trade.
What is Trident Lifeline's market capitalisation?
Ans. Trident Lifeline's market capitalisation is Rs 480.79 crore. That size is below the sector median in the supplied same-industry benchmark, which helps place the stock's move in context. The company operates in the Healthcare sector.
What does Trident Lifeline's P/E ratio show?
Ans. Trident Lifeline's P/E ratio is 23.81. In the supplied same-industry set, that is below the sector median of 32.73 and below the sector average of 49.58, which offers valuation context.
What do ROE and ROCE show for Trident Lifeline?
Ans. ROE is 18.78% and ROCE is 19.17%. Both are above the supplied sector median and sector average, which gives the Trident Lifeline Share Price some financial context without implying a forecast.
How does Trident Lifeline compare with healthcare peers?
Ans. Trident Lifeline is much smaller in market cap than peers such as Sun Pharmaceutical, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E is also lower than most of the named peers in the supplied comparison set.
Is Trident Lifeline's dividend yield positive?
Ans. The supplied dividend yield is 0. That means the current data does not show a dividend yield, so investors following Trident Lifeline Share Price should rely on earnings, book value and return ratios for context.
Recent Articles

Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026

Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026

Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026

Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





